GLAXOSMITHKLINE PHARMACEUTICALS
|
The Current P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 9.56.
Share Price | ₹1,868.9 | Apr 19,2024 |
Market Cap | ₹31,658.3 Cr | |
Sales-TTM | ₹3,311.4 Cr | TTM-Consolidated Results |
Price/Sales | 9.56x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLAXOSMITHKLINE PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹31,658.3 Cr] as on Apr 19,2024
(/) Sales [ ₹3,311.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 9.56x ]
Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay '9.56 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLAXOSMITHKLINE PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS
PS Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 7.48x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/e ratio of 7.04x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 8.59x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 6.54x.
How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLAXOSMITHKLINE PHARMACEUTICALS | 3,311.4 | 9.56 | 31,658.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.70 | 365,311.0 |
CIPLA LTD | 25,350.2 | 4.28 | 108,623.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.64 | 99,134.3 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 4.88 | 92,794.9 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.00 | 97,408.4 |
MANKIND PHARMA LTD | 9,946.3 | 9.41 | 93,565.4 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.20 | 85,858.5 |
LUPIN LTD | 19,480.1 | 3.62 | 70,506.8 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.28 | 63,697.4 |
ABBOTT INDIA LTD | 5,753.4 | 9.65 | 55,528.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.28x |
Max industry PS | 13.00x |
Median industry PS | 7.70x |
Average industry PS | 6.93x |
You may also like the below Video Courses